InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Busky Joseph M., Chief Financial Officer. Officer active across 1 company, notably QuidelOrtho Corp. Cumulatively, 15 disclosures have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €334k. Activity tracked since 1 June 2023. The latest transaction was disclosed on 28 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Busky Joseph M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
1,519 shares@ US$14.780.0022% mcap12.7% of flowCommon StockSEC:0001385091-26-000012:1
4,925 shares0Common StockSEC:0001385091-26-000012:0
3,370 shares@ US$23.66230.0095% mcap50.0% of flowCommon StockSEC:0001385091-26-000010:0
Canonical exit: 14 May 2026 (T+90)
3,370 shares@ US$23.662325.7% of flowCommon StockSEC:0001385091-26-000008:0
Canonical exit: 14 May 2026 (T+90)
5,968 shares0Common StockSEC:0001385091-26-000006:0
8,425 shares0Common StockSEC:0001385091-26-000002:0
4,770 shares@ US$26.059855.5% of flowCommon StockSEC:0001385091-25-000005:0
Canonical exit: 22 Feb 2026 (T+90)
21,367 shares0Common StockSEC:0001906324-25-000140:0
5,392 shares0Common StockSEC:0001906324-25-000133:0
4,925 shares0Common StockSEC:0001906324-25-000041:0
5,968 shares0Common StockSEC:0001906324-25-000029:0
5,391 shares0Common StockSEC:0000950170-24-068675:0
4,925 shares0Common StockSEC:0000950170-24-039666:0
2,150 shares@ US$46.355100.0% of flowCommon StockSEC:0000950170-24-020435:0
Canonical exit: 23 May 2024 (T+90)
5,391 shares0Common StockSEC:0001209191-23-034578:0
15 of 15 declarations
About Busky Joseph M.
Joseph M. Busky is the Chief Financial Officer of QuidelOrtho Corp. In this role, he oversees the company's financial management, including budgeting, financial analysis, and regulatory compliance. With deep expertise in corporate finance, he plays a key role in making strategic decisions that support QuidelOrtho's growth and profitability. His experience enables him to effectively navigate the financial challenges of the industry.
